This is not an attack, same was true last year, same was true...

First 44 Last

Share
Profile

Follow
Raki

2,709 Posts.

710

07/01/22

14:41

Post #: 58708299
Share

Originally posted by kierancrowe: ↑

Take of this statement what you will about how information is delivered and why it may not be providing the SP gains we expect. There is a saying, “Loose lips sink ships.”.

Before you slam me for it, of all the great announcements lately are any not already known by the market? We knew we were going to get $6m+ in R&D tax incentives as we had already been told.

We have been told there are 3-4 new phase 2 trials to begin with one being sponsored. So far we have had 2 of them announced, whomever those collaborations are with it was always guaranteed to be with big pharma etc except for most likely the sponsored trial.

The recent PD1-VAX announcement lacked the detail to break the current trend as it gave us nothing we didn’t know or weren’t expecting.

We have been told there will be 6-8 trials running next year. Everything is already public knowledge. We are starved of “NEW” information to create buying interest in our stock and this is why we are over sold.

If HERVaxx results aren’t mind blowing there could be more pain as only CF33 results will be able to light a fire under the SP.

Attack away

Expand

This is not an attack, same was true last year, same was true when share price hit 0.6, same was true when Alex left, same was true when US FED announced rate hikes, same was true when Djokovic got his Aussie Visa , no bad news, all the announcements have been to the mark and have met deadlines (very rare with biotechs), the question is not the lack of good or known announcements, questions is why even with status quo, stock is getting smashed, its the lack of event based cause, not the cause due to some bad events....

IMU Price at posting: 36.0¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply